Catalent has agreed to acquire Bettera Holdings, a Plano, Texas-based manufacturer of gummy, soft chew, and lozenger products for the nutritional supplements market, for $1 billion.

Bettera develops and produces nutraceutical, functional, and botanical ingredients and has four production facilities in the US. The acquisition complements Catalent’s softgel and oral dose formulation development and manufacturing business. Bettera will complement and use Catalent’s network of consumer health manufacturing sites across North and South America, Europe, and Japan to support the global consumer health and beauty markets.

Bettera is currently owned by Highlander Partners, a Dallas, Texas-based private investment firm, Highlander formed Bettera through a series of four acquisitions beginning in 2017 and shaped it into a manufacturer of nutritional vitamins, minerals and supplements.

The acquisition is subject to customary terms and closing conditions and is expected to close before the end of 2021. The acquisition includes the transfer of substantially all Bettera’s approximately 500 employees and product development, manufacturing, and packaging assets of Bettera Holdings, including its production facilities in California, Indiana, New Jersey, and Virginia.

Source: Catalent and Highlander Partners